会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein JunKinases
    • 携带亲脂性和可离子化部分的药学活性磺酰胺衍生物作为蛋白质JunKinases的抑制剂
    • US07544700B2
    • 2009-06-09
    • US10381665
    • 2001-09-27
    • Serge HalazyDennis ChurchStephen J. ArkinstallMarco BiamonteMontserrat CampsJean-Pierre GottelandThomas Rueckle
    • Serge HalazyDennis ChurchStephen J. ArkinstallMarco BiamonteMontserrat CampsJean-Pierre GottelandThomas Rueckle
    • A61P25/00A61P25/16A61K31/4535A61K31/55A61K31/4025C07D333/34C07D409/12C07D409/14C07D413/14
    • C07D409/12C07D333/34C07D409/14C07D413/14
    • The present invention is related to sulfonamide derivatives having a lipophilic moiety and which are substantially soluble. Said compounds are notably for use as pharmaceutically active compounds. The present invention also related to pharmaceutical formulations containing such sulfonamide derivatives. Said sulfonamide derivatives are efficient modulators of the JNK pathway, they are in particular efficient and selective inhibitors of JNK 2 and 3. The present invention is furthermore related to novel sulfonamide derivatives as well as to methods of their preparation. The compounds of formula (I) according to the present invention being suitable pharmaceutical agents are those wherein Ar1 and Ar2 are independently from each other substituted or unsubstituted aryl or heteroaryl groups, X is O or S, preferably O; R1 is hydrogen or a C1-C6-alkyl group, or R1 forms a substituted or unsubstituted 5-6-membered saturated or unsaturated ring with Ar1; n is an integer from 0 to 5, preferably between 1-3 and most preferred 1; Y within formula (I) is an unsubstituted or a substituted 4-12-membered saturated cyclic or bicyclic alkyl which is substituted with at least one ionizable moiety to which a lipophilic chain is attached and which is containing at least one nitrogen atom, whereby one nitrogen atom within said ring is forming a bond with the sulfonyl group of formula (I) thus providing a sulfonamide.
    • 本发明涉及具有亲油部分并且基本上可溶的磺酰胺衍生物。 所述化合物特别用作药物活性化合物。 本发明还涉及含有这种磺酰胺衍生物的药物制剂。 所述磺酰胺衍生物是JNK途径的有效调节剂,它们特别是JNK 2和3的有效和选择性抑制剂。本发明还涉及新型磺酰胺衍生物及其制备方法。 根据本发明的式(I)化合物是合适的药物,其中Ar 1和Ar 2彼此独立地为取代或未取代的芳基或杂芳基,X为O或S,优选为O; R1是氢或C1-C6-烷基,或R1与Ar1形成取代或未取代的5-6元饱和或不饱和环; n为0至5的整数,优选1-3至最优选1; 式(I)中的Y是未被取代的或取代的4-12元饱和的环状或双环烷基,其被至少一个亲电链连接的可离子化部分取代,并且含有至少一个氮原子,其中一个 所述环内的氮原子与式(I)的磺酰基形成键,从而提供磺酰胺。
    • 9. 发明授权
    • Pharmaceutically active sulfonyl hydrazide derivatives
    • 药物活性磺酰肼衍生物
    • US07432286B1
    • 2008-10-07
    • US10088074
    • 2000-09-28
    • Stephen ArkinstallSerge HalazyDennis ChurchMontserrat CampsThomas RueckleJean-Pierre GottelandMarco Biamonte
    • Stephen ArkinstallSerge HalazyDennis ChurchMontserrat CampsThomas RueckleJean-Pierre GottelandMarco Biamonte
    • C07D417/12C07D213/74A61K31/44
    • C07D213/74C07D409/12C07D409/14C07D417/12C07D417/14
    • The present invention is related to sulfonyl hydrazide derivatives for use as pharmaceutically active compounds, as well as to pharmaceutical formulations containing such sulfonyl hydrazide derivatives. Said sulfonyl hydrazide derivatives are efficient modulators of the JNK pathway, they are in particular efficient inhibitors of JNK 2 and 3. The present invention is furthermore related to novel sulfonyl hydrazide derivatives as well as to methods of their preparation. In Formula (I) Ar1 and Ar2 are independently from each other an unsubstituted or substituted aryl or beteroaryl group, X1 and X2 are independently from each other O or S; R1, R2, R3 are independently from each other hydrogen or a C1-C6-alkyl substituent or R1 forms a substituted or unsubstituted 5-6-membered saturated or unsaturated ring with Ar1; or R2 and R3 form a substituted or unsubstituted 5-6-membered saturated or unsaturated ring; n is an integer from 0 to 5; G is selected from a group comprising or consisting of an unsubstituted or substituted 4-8 membered heterocycle containing at least one heteroatom, or G is a substituted or unstibstituted C1-C6-alkyl group.
    • 本发明涉及用作药物活性化合物的磺酰肼衍生物以及含有这种磺酰肼衍生物的药物制剂。 所述磺酰肼衍生物是JNK途径的有效调节剂,它们特别是JNK 2和3的有效抑制剂。本发明还涉及新型磺酰肼衍生物及其制备方法。 在式(I)中,Ar 1和Ar 2彼此独立地为未取代或取代的芳基或双芳基,X 1和X 2独立地为 SUP> 2 彼此独立地为O或S; R 1,R 2,R 3,3彼此独立地为氢或C 1 -C 3 > 6个 - 烷基取代基或R 1'与Ar 1形成取代或未取代的5-6元饱和或不饱和的环; 或R 2和R 3形成取代或未取代的5-6元饱和或不饱和环; n为0〜5的整数, G选自包含至少一个杂原子的未取代或取代的4-8元杂环或由其组成,或G是取代或未取代的C 1 -C 6 烷基。